AnodyneWiki

Phenylpropanolamine

PPA
Phenylpropanolamine
Salts
[]
Phenylpropanolamine maleate
Phenylpropanolamine maleate
Phenylpropanolamine hydrochloride
Phenylpropanolamine hydrochloride
Phenylpropanolamine bitartrate
Phenylpropanolamine bitartrate
Phenylpropanolamine hemisulfate
Phenylpropanolamine hemisulfate
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass151.21 g/mol [1]
AppearanceWhite, crystalline powder [1]
OdorSlight aromatic odor [1]
Melting point190-194 °C [1]
DecompositionWhen heated to decomposition it emits very toxic fumes of nitroxides. [1]
SolubilityFreely soluble [1]
Predicted LogP0.8 [1]
Structural Identifiers
[]
Molecular formulaC9H13NO
IUPAC name(1R,2S)-2-amino-1-phenylpropan-1-ol
SMILESC[C@@H]([C@@H](C1=CC=CC=C1)O)N
InChIInChI=1S/C9H13NO/c1-7(10)9(11)8-5-3-2-4-6-8/h2-7,9,11H,10H2,1H3/t7-,9-/m0/s1
InChIKeyDLNKOYKMWOXYQA-CBAPKCEASA-N
CAS number14838-15-4
UNII33RU150WUN
PubChem CID10297
Pharmacokinetics[]
OnsetOral: 15–30 minutes
Elimination half-life4 hours (range 3.7–4.9 hours)[3]
Duration of actionOral: 3 hours
MetabolismMinimal (3–4%)
ExcretionUrine: 90% (unchanged)
Routes of administrationBy mouth
Toxicity
[]
Rat:
- oral: 1490 mg/kg /Phenylpropanolamine
- sc: 850 mg/kg
 [1]

Phenylpropanolamine (also known as Propadrine, Fenilpropanolamina, erythro-2-Amino-1-phenyl-1-propanol, Phenylpropanolaminum, Phenylfenesin, Rinexin, Fansia, Benzenemethanol, α-(1-aminoethyl)-, (R*,S*)-(+-)-, Phenylpropanolamine 1534 or R01ba01) is a sympathomimetic substance of the amphetamine and phenylethanolamine class.

Chemistry

Salts []

Phenylpropanolamine is typically found in the form of its maleate, hydrochloride, bitartrate and hemisulfate salts.

 []

Phenylpropanolamine is a single defined stereoisomer (optical activity ( + / - )).

Phenylpropanolamine matches Lipinski's rule of five.

There are currently 2 reagent-interactions on

ReagentColor changeDescription
Robadopepink
Simon'sno blue color change

Pharmacology

Mechanism of action []

Phenylpropanolamine acts directly on alpha- and, to a lesser degree, beta-adrenergic receptors in the mucosa of the respiratory tract. Stimulation of alpha-adrenergic receptors produces vasoconstriction, reduces tissue hyperemia, edema, and nasal congestion, and increases nasal airway patency. PPA indirectly stimulates beta-receptors, producing tachycardia and a positive inotropic effect. [1]

Prodrugs of phenylpropanolamine: Cafedrine.

Interactions []

Interaction mechanisms documented in (number of interacting drugs):

inhibition19 (2 contraindicated)
shared target7 (1 contraindicated)
shared target5 (1 contraindicated)
shared target3 (1 contraindicated)
shared target3 (1 contraindicated)
shared target3 (1 contraindicated)
shared target2 (2 contraindicated)
shared target2 (2 contraindicated)
shared target2 (2 contraindicated)
shared target2 (1 contraindicated)

Medical side effects []

40 side effects listed on drug labels in (phenylpropanolamine).

  • Anxiety
  • Arrhythmia
  • Ataxia
  • Confusional state
  • Feeling abnormal
  • Constipation
  • Dizziness
  • Somnolence
  • Dyskinesia
  • Dyspnoea
  • Dermatitis
  • Rash
  • Flushing
  • Hallucination
  • Hypersensitivity
  • Hypotension
  • Irritability
  • Renal tubular necrosis
  • Nausea
  • Nervousness
  • Tension
  • Psychotic disorder
  • Tachycardia
  • Tremor
  • Vomiting
  • Urinary retention
  • Agitation
  • Hepatocellular injury
  • Liver injury
  • Urinary hesitation
  • Dysphoria
  • Respiratory depression
  • Pulmonary function test decreased
  • Euphoric mood
  • Vision blurred
  • Blood pressure increased
  • Coordination abnormal
  • Antitussive therapy
  • Serotonin syndrome
  • Insomnia

Indications

  • Ache
  • Body temperature increased
  • Common cold
  • Cough
  • Discomfort
  • Headache
  • Hypersensitivity
  • Nasal congestion
  • Pain
  • Rhinorrhoea
  • Seasonal allergy
  • Sinusitis
  • Sneezing

Subjective effects []

 []

  • Australia: Phenylpropanolamine is a Schedule 4.
  • Brazil: Phenylpropanolamine is a F3.[4]
  • Canada: Phenylpropanolamine is a Schedule VI.
  • United States: Phenylpropanolamine is Prescription only.

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 10297, Phenylpropanolamine. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/10297
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Phenylpropanolamine. UNII: 33RU150WUN. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/33RU150WUN
  3. Phenylpropanolamine: Uses, Interactions, Mechanism of Action. DrugBank Online. 29 June 2018. https://go.drugbank.com/drugs/DB00397
  4. RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-07-24. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 09:00:24
drugsprook2026-11-20 09:00:20
erowidmissing (no Erowid substance of that name)2026-11-20 09:00:20
gsrsok2026-11-20 09:00:23
hmdbmissing (no HMDB id)2026-11-20 09:00:20
keggok2026-11-20 09:00:21
pubchemok2026-11-20 09:00:20
redditmissing (no r/tripreports posts mention it)2026-11-20 09:00:20
siderok2026-11-20 09:00:20
structureok2026-11-20 09:00:20
wikipediaok2026-11-20 09:00:20